TUE guidance documents including new regulations on glucocorticoids In order to assist physicians and athletes, in the last few weeks, WADA published the following guidance documents on managing TUEs to include the new regulations on glucocorticoids: General document on glucocorticoids and TUEs Checklists for athletes and treating physicians on a number of medical conditions for which glucocorticoids may be used TUE Physician Guidelines for TUE Committees on how to evaluate TUE requests for glucocorticoids for different medical conditions Educational resources In addition to the guidance documents listed above, WADA has provided, or will provide, a number of educational resources as part of its Code Implementation Support Program (CISP), which can be accessed on the Agencys Anti-Doping Education and Learning Platform (ADEL)
No lipotropic injection has been approved for the treatment of obesity or overweight
Certificate of Analysis Certificates of Analysis Janoshik Third-party tested Independent analytical lab Latest safety testing Sterility TAMC/TYMC Jul 2026 Heavy metals As/Cd/Pb not detected Feb 2026 Endotoxin 8.159 EU/vial Feb 2026 Endotoxin, sterility, and heavy-metals reports are run on individual lots on a rotating basis, separate from the identity/purity assay above not on every lot
Product Frequently Researched Together Products commonly paired for complementary research applications Age Verification Required You must be 21 years or older to access this website
Int J Clin Pharmacol Ther Toxicol
& Ablasser, A
/assets/production/practices/bb098bde1976b73281d3b963c3dfa64815de4cfc/images/2780384.jpeg)
